ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,113Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1171

$913K Total Retail Price of All Prescriptions

Rank: 53 out of 1171

451 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 12,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,263 655 S3 1 8
LISINOPRIL 637 515 2 3
SIMVASTATIN 626 483 3 1
FUROSEMIDE 534 441 4 6
AMLODIPINE BESYLATE 515 430 5 2
OMEPRAZOLE 460 346 6 5
WARFARIN SODIUM 370 318 7 12
METOPROLOL TARTRATE 349 288 8 11
HYDROCHLOROTHIAZIDE 330 297 9 9
TRAMADOL HCL 321 255 10 18
LEVOTHYROXINE SODIUM 285 262 11 4
METFORMIN HCL 266 185 12 7
CARVEDILOL 256 230 13 20
NEXIUM 252 186 14 25
LOSARTAN POTASSIUM 208 165 15 14
KLOR-CON M20 206 150 16 41
GABAPENTIN 192 106 17 16
TAMSULOSIN HCL 191 137 18 28
CRESTOR 183 163 19 27
ZOLPIDEM TARTRATE 172 142 20 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 107 21 26
ATORVASTATIN CALCIUM 163 137 22 10
SPIRIVA 156 125 23 57
HYDRALAZINE HCL 147 112 24 60
GLIMEPIRIDE 145 126 25 34
PROAIR HFA 141 81 26 49
COLCRYS 139 133 27 159
PREDNISONE 138 127 28 39
ISOSORBIDE MONONITRATE ER 135 127 29 44
CIPROFLOXACIN HCL 132 105 30 61
ADVAIR DISKUS 124 95 31 51
ACTOS 121 88 32 123
JANUVIA 119 86 33 66
LOSARTAN-HYDROCHLOROTHIAZIDE 118 76 34 40
AZITHROMYCIN 117 82 35 43
OXYCODONE-ACETAMINOPHEN 114 72 S2 36 59
POTASSIUM CHLORIDE 114 100 36 19
SERTRALINE HCL 114 62 36 23
PROMETHAZINE HCL 105 55 R 39 87
OXYCODONE HCL-ACETAMINOPHEN 103 42 S2 40 99
DONEPEZIL HCL 103 103 40 24
ATENOLOL 101 90 42 15
MELOXICAM 101 54 42 56
METOPROLOL SUCCINATE 101 96 42 17
NAMENDA 101 101 42 42
LANTUS 95 65 46 46
PANTOPRAZOLE SODIUM 95 65 46 29
DIOVAN 90 66 48 32
ACETAMINOPHEN-CODEINE 90 72 S3 48 121
GLIPIZIDE 88 50 50 47
CARISOPRODOL 88 0 R 50 160
ALENDRONATE SODIUM 86 66 52 33
CLOPIDOGREL 86 83 52 35
PLAVIX 84 79 54 55
INSULIN SYRINGE 81 44 55 71
TRAZODONE HCL 79 46 56 37
FLUTICASONE PROPIONATE 77 70 57 30
RANITIDINE HCL 77 47 57 38
ENALAPRIL MALEATE 73 48 59 73
SINGULAIR 73 43 59 78
PAROXETINE HCL 72 71 61 62
FINASTERIDE 69 57 62 88
ISOSORBIDE DINITRATE 68 55 63 213
COMBIVENT 62 42 64 152
DIGOXIN 62 53 64 68
RISPERIDONE 60 47 66 77
ZETIA 59 59 67 63
DILTIAZEM 24HR CD 59 55 67 101
CELEBREX 58 25 69 100
MOMETASONE FUROATE 57 50 70 266
AMITRIPTYLINE HCL 56 30 R 71 74
DIOVAN HCT 56 49 71 65
SPIRONOLACTONE 55 34 73 53
NIASPAN 55 36 73 136
CYCLOBENZAPRINE HCL 55 19 R 73 67
LORAZEPAM 54 40 76 335
QUINAPRIL HCL 53 49 77 156
DILTIAZEM 24HR ER 53 49 77 112
CYMBALTA 53 22 77 64
VERAPAMIL ER 52 40 80 91
QUETIAPINE FUMARATE 51 50 81 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.